Lack of effective translational regulation of PLD expression and exosome biogenesis in triple-negative breast cancer cells
- 8 August 2018
- journal article
- review article
- Published by Springer Nature in Cancer and Metastasis Reviews
- Vol. 37 (2-3) , 491-507
Abstract
Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer that is difficult to treat since cells lack the three receptors (ES, PR, or HER) that the most effective treatments target. We have used a well-established TNBC cell line (MDA-MB-231) from which we found evidence in support for a phospholipase D (PLD)-mediated tumor growth and metastasis: high levels of expression of PLD, as well as the absence of inhibitory miRs (such as miR-203) and 3′-mRNA PARN deadenylase activity in these cells. Such findings are not present in a luminal B cell line, MCF-7, and we propose a new miR•PARN•PLD node that is not uniform across breast cancer molecular subtypes and as such TNBC could be pharmacologically targeted differentially. We review the participation of PLD and phosphatidic acid (PA), its enzymatic product, as new “players” in breast cancer biology, with the aspects of regulation of the tumor microenvironment, macrophage polarization, regulation of PLD transcripts by specific miRs and deadenylases, and PLD-regulated exosome biogenesis. A new signaling miR•PARN•PLD node could serve as new biomarkers for TNBC abnormal signaling and metastatic disease staging, potentially before metastases are able to be visualized using conventional imaging.Keywords
This publication has 238 references indexed in Scilit:
- Deubiquitinating enzyme USP22 positively regulates c‐Myc stability and tumorigenic activity in mammalian and breast cancer cellsJournal of Cellular Physiology, 2017
- Potential Implications for Designing Drugs Against the Brown Spider Venom Phospholipase‐DJournal of Cellular Biochemistry, 2016
- Calcium signals inhibition sensitizes ovarian carcinoma cells to anti-Bcl-xL strategies through Mcl-1 down-regulationApoptosis, 2015
- Association of a polymorphism of the phospholipase D2 gene with the prevalence of colorectal cancerJournal of Molecular Medicine, 2003
- The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapiesThe Journal of Pathology, 2002
- Transformation of Cells Overexpressing a Tyrosine Kinase by Phospholipase D1 and D2Biochemical and Biophysical Research Communications, 2001
- Increased Activity and Intranuclear Expression of Phospholipase D2 in Human Renal CancerBiochemical and Biophysical Research Communications, 2000
- Analysis of Myc/Max/Mad network members in adipogenesis: Inhibition of the proliferative burst and differentiation by ectopically expressed Mad1Journal of Cellular Physiology, 2000
- Cytokine regulation of angiogenesis in breast cancer: the role of tumor-associated macrophagesJournal of Leukocyte Biology, 1995
- Identification of phospholipase D (PLD) activity in mouse peritoneal macrophagesInflammation Research, 1993